Veradermics (MANE) Payables (2024 - 2026)

Veradermics (MANE) has 3 years of Payables data on file, last reported at $1.1 million in Q1 2026.

• Quarterly Payables changed N/A year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (changed N/A YoY) and the FY2025 annual result came in at $2.1 million, down 5.43% from the prior year.
• Payables slipped to $1.1 million in Q1 2026, from $2.1 million in the prior quarter.
• In the past five years, Payables ranged from a high of $2.2 million in Q4 2024 to a low of $1.1 million in Q1 2026.
• A 3-year average of $1.8 million and a median of $2.1 million in 2025 frame the typical range for Payables.
• The widest YoY moves for Payables: up 5.43% in 2025, down 5.43% in 2025.
• Tracing MANE's Payables over 3 years: stood at $2.2 million in 2024, then dropped by 5.43% to $2.1 million in 2025, then sank by 49.62% to $1.1 million in 2026.
• The last three Payables figures came in at $1.1 million (Q1 2026), $2.1 million (Q4 2025), and $2.2 million (Q4 2024), per Business Quant data.